Characteristic | No. of patients (%) n = 119 |
---|---|
Median age, years (range) | 60 (19-84) |
Sex | |
Male | 88 (73.9) |
Female | 31 (26.1) |
ECOG performance status | |
0 | 80 (67.2) |
1 | 35 (29.4) |
2 | 4 (3.4) |
Charlson comorbidity index (age-adjusted) | |
< 4 | 53 (44.5) |
4-7 | 61 (51.3) |
≥ 8 | 5 (4.2) |
Smoking history (pack/years) | |
0 | 19 (21.2) |
< 10 | 15 (16.6) |
10-20 | 11 (12.2) |
> 20 | 45 (50.0) |
Primary tumor | |
Oropharynx | 68 (57.1) |
Larynx | 19 (15.8) |
Hypopharynx | 10 (8.5) |
Nasopharynx | 22 (18.6) |
HPV status (oropharynx only) | |
Positive | 32 (47.0) |
Negative | 22 (32.4) |
Unknown | 14 (20.6) |
T stage at diagnosis (VIIth ed) | |
1 | 11 (9.3) |
2 | 36 (30.2) |
3 | 31 (26.0) |
4a/4b | 41 (34.5) |
N stage at diagnosis (VIIth ed) | |
0 | 26 (21.9) |
1 | 19 (16.0) |
2a/2b/2c | 73 (61.4) |
3 | 1 (0.7) |
AJCC stage at diagnosis (VIIth ed) | |
I-II | 10 (8.4) |
III | 27 (22.7) |
IVA | 76 (63.9) |
IVB | 6 (5.0) |
Primary treatment modality | |
RT | 14 (11.8) |
Induction CT + RT | 2 (1.7) |
Induction CT + RCT | 23 (19.3) |
Induction CT + BRT | 2 (1.7) |
CRT | 65 (54.6) |
BRT | 13 (10.9) |